Bridge to Life Ltd.

Bridge to Life Ltd. is a biotechnology company based in Northbrook, Illinois, specializing in organ preservation, perfusion, and revitalization solutions for transplantation. The company develops and manufactures preservation fluids, hypothermic oxygenated perfusion (HOPE) systems, and related consumables for organ procurement organizations (OPOs) and transplant centers globally. Key products include the Belzer UW® cold storage solution and machine perfusion solution (gold-standard preservation fluids), VitaSmart™ hypothermic oxygenated perfusion system (FDA DE NOVO cleared for HOPE), EasiSlush® sodium chloride solution for slush preparation, and French-sized cannula tubing for organ procurement. The company supports the transplant community with preservation technologies designed to improve organ viability, extend preservation windows, and enhance recipient outcomes. Bridge to Life maintains partnerships with leading transplant institutions and conducts clinical research, including the Bridge to HOPE trial evaluating VitaSmart™ in liver transplantation.